Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leigh Delbridge

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Clinical Endocrinology|February 7, 2015
Is there a role for an ultrasensitive thyroglobulin assay in patients with serum antithyroglobulin antibodies? A large (Australian) cohort study in differentiated thyroid cancerRachel T McGrath, Veronica A Preda, Philip Clifton-Bligh, et al.
Cardiovascular Research|December 31, 2002
Chronic amiodarone-induced inhibition of the Na+-K+ pump in rabbit cardiac myocytes is thyroid-dependent: comparison with dronedaroneAndrew D Pitt, Clyne Fernandes, Nerida L Bewick, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2012
Association of FOXE1 polyalanine repeat region with papillary thyroid cancerMartyn Bullock, Emma L Duncan, Christine O'Neill, et al.
Annals of Surgical Oncology|September 30, 2010
Medullary thyroid carcinoma: long-term outcomes of surgical treatmentDeepak T Abraham, Tsu-Hui Low, Marinella Messina, et al.
Oncogene|March 6, 2003
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomasDiana E Benn, Michael S Croxson, Kathy Tucker, et al.
Thyroid : Official Journal of the American Thyroid Association|October 3, 2013
A preoperative nomogram for the prediction of ipsilateral central compartment lymph node metastases in papillary thyroid cancerAndrew M Thompson, Robin M Turner, Andrew Hayen, et al.
Clinical Endocrinology|December 16, 2015
TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomasMartyn Bullock, Yan Ren, Christine O'Neill, et al.
Endocrine-Related Cancer|December 23, 2009
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumorsMichael A Hahn, Viive M Howell, Anthony J Gill, et al.
Surgery|September 14, 2019
Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancerJayani Jayasekara, Pascal Jonker, Jia Feng Lin, et al.
The Oncologist|August 26, 2023
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative SurgeryAlexander J Papachristos, Laura E Nicholls, Robert Mechera, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Clinical Endocrinology|February 7, 2015
Is there a role for an ultrasensitive thyroglobulin assay in patients with serum antithyroglobulin antibodies? A large (Australian) cohort study in differentiated thyroid cancerRachel T McGrath, Veronica A Preda, Philip Clifton-Bligh, et al.
Cardiovascular Research|December 31, 2002
Chronic amiodarone-induced inhibition of the Na+-K+ pump in rabbit cardiac myocytes is thyroid-dependent: comparison with dronedaroneAndrew D Pitt, Clyne Fernandes, Nerida L Bewick, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2012
Association of FOXE1 polyalanine repeat region with papillary thyroid cancerMartyn Bullock, Emma L Duncan, Christine O'Neill, et al.
Annals of Surgical Oncology|September 30, 2010
Medullary thyroid carcinoma: long-term outcomes of surgical treatmentDeepak T Abraham, Tsu-Hui Low, Marinella Messina, et al.
Oncogene|March 6, 2003
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomasDiana E Benn, Michael S Croxson, Kathy Tucker, et al.
Thyroid : Official Journal of the American Thyroid Association|October 3, 2013
A preoperative nomogram for the prediction of ipsilateral central compartment lymph node metastases in papillary thyroid cancerAndrew M Thompson, Robin M Turner, Andrew Hayen, et al.
Clinical Endocrinology|December 16, 2015
TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomasMartyn Bullock, Yan Ren, Christine O'Neill, et al.
Endocrine-Related Cancer|December 23, 2009
CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumorsMichael A Hahn, Viive M Howell, Anthony J Gill, et al.
Surgery|September 14, 2019
Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancerJayani Jayasekara, Pascal Jonker, Jia Feng Lin, et al.
The Oncologist|August 26, 2023
Management of Medullary Thyroid Cancer: Patterns of Recurrence and Outcomes of Reoperative SurgeryAlexander J Papachristos, Laura E Nicholls, Robert Mechera, et al.
Pageof 10